Talcum Powder Cancer Lawsuit

All 14 Members Of The Talcum Powder Cancer MDL Steering Committee Reject Johnson & Johnson's Presumptive $11 Billion Offer

Plaintiff lawyers think Johnson & Johnson is trying to get away with having misrepresented the safety of their baby powder products by misusing the bankruptcy court

Thursday, April 6, 2023 - Despite media reports to the contrary, no settlement has been reached in the Johnson's Baby Powder cancer litigation leaving a reported 60,000 lawsuits against the company unrestricted and able to go to trial. According to sources, the media misinterpreted the newest talcum powder cancer settlement offer as being a done deal and that in reality, it was an attempt to circumvent the decisions of the 3rd Circuit Court which rejected the company's talcum powder subsidiary's bankruptcy scheme. Johnson & Johnson has refiled LTL Management for bankruptcy and added $9 billion to the $2 billion already funding the company.

Talcum powder ovarian cancer lawsuits are organized into multidistrict litigation (MDL) and presided over by U.S. District Judge Michael A. Shipp who recently took over the litigation from Judge Freda Wolfson in the U.S. District Court for the District of New Jersey. Lawyers representing the talcum powder cancer MDL steering committee told Yahoo Finance News, " The talc "settlement" being touted by J&J and the media is NOT a settlement. It is an illusory proposal for a bankruptcy plan, yet another attempt by J&J to misuse the bankruptcy system. All 14 members of the plaintiffs' steering committee reject this proposal." Lawyers think the amount being offered may sound like a lot of money, but when divided among the 60,000 plaintiffs does not come close to paying for a talcum powder ovarian cancer victim's medical costs, lost wages, pain, and suffering, nor allows for punitive damages. Lawyers for the MDL steering committee told YN, " While J&J's proposed $8.9 billion offer sounds like a lot of money, it is not enough when you consider the terms of the proposal. This settlement proposal would pay far less than $120,000 per case if that." Lottery-sized punitive damages are what J & J would like to avoid as juries have been incensed when told of the company's despicable and reprehensible corporate behavior as one Missouri Appeals Court judge put it. In 20018, a Missouri Appeals Court denied Johnson & Johnson's attempt to overturn a $4 billion jury award to 22 women with ovarian cancer. The judge was furious over the testimony he reviewed, as the AP reported: " St. Louis Circuit Judge Rex Burlison, in a ruling Wednesday, cited evidence of what he called "particularly reprehensible conduct" by Johnson & Johnson. Burlison wrote that "defendants knew of the presence of asbestos in products that they knowingly targeted for sale to mothers and babies, knew of the damage their products caused, and misrepresented the safety of these products for decades." The number of talcum powder ovarian cancer lawsuits against Johnson & Johnson has swelled to more than 60,000 from a reported 40,000 last year as more women with the deadly disease come forward. Women with ovarian cancer allege that using Johnson's Baby Powder and Shower to Shower regularly for many years contributed to developing their disease.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.